NEUBASE THERAPEUTICS INC's ticker is NBSE and the CUSIP is 64132K102. A total of 1 filers reported holding NEUBASE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CARNEGIE MELLON UNIVERSITY | 46,970 | $40,855 | 0.05% |
External links
This page lists NEUBASE THERAPEUTICS INC's shareholders in Q3 2023. To view NEUBASE THERAPEUTICS INC's shareholder history, click here.